JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

A3009 Sorafenib

2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
B5549 PF-3644022

Target: MK2

Summary: Potent and Selective MK2 inhibitor

<14.98 mg/mL
A3018 Trametinib (GSK1120212)

7 Citation

Target: MEK

Summary: MEK1 and MEK2 inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
A8254 SB 203580

9 Citation

Target: p38|PKB

Summary: P38 MAP kinase inhibitor

insoluble in H2O; ≥18.872 mg/mL
B2227 BI-D1870

1 Citation

Target: p90 S6K

Summary: P90 RSK inhibitor,ATP-competitive and cell-permeable

insoluble in H2O; ≥19.55 mg/mL
A8245 Sorafenib Tosylate

1 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥31.85 mg/mL
A3347 Dabrafenib Mesylate (GSK-2118436)

Target: Raf

Summary: Inhibitor of BRAF(V600) mutants

≥30.75 mg/mL
A8313 RAF265

Target: Raf|VEGFR

Summary: Multiple intracellular kinases inhibitor

≥25.9 mg/mL